{
    "nctId": "NCT05823467",
    "briefTitle": "What is Optimal Post-operative Prophylactic Therapy in Irradiated Breasts Undergoing Repeat Surgery",
    "officialTitle": "What is Optimal Post-operative Prophylactic Therapy in Irradiated Breasts Undergoing Repeat Oncologic Surgery to Reduce Early Wound Complications",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 105,
    "primaryOutcomeMeasure": "Rate of Wound Complication",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* \\> 18 years of age\n* Previous breast surgery and ipsilateral breast irradiation\n* Requiring repeat breast surgery\n\nExclusion Criteria:\n\n* Male\n* \\<18 years of age,\n* Currently on antibiotic therapy for other indications\n* Known hypersensitivity to trimethoprim or sulfonamides,\n* History of drug-induced immune thrombocytopenia with use of trimethoprim and/or sulfonamides\n* Documented megaloblastic anemia due to folate deficiency\n* Currently pregnant or breastfeeding, and\n* Marked hepatic damage\n* Severe renal insufficiency\n* Severe sensitivity or allergy to silicone adhesive",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}